# Aspirin Non-responsiveness and Clopidogrel Endpoint Trial.

> **NCT00222261** · PHASE4 · COMPLETED · sponsor: **Ullevaal University Hospital** · enrollment: 1001 (actual)

## Conditions studied

- Coronary Heart Disease
- Angina Pectoris
- Atherosclerosis

## Interventions

- **DRUG:** aspirin
- **DRUG:** clopidogrel

## Key facts

- **NCT ID:** NCT00222261
- **Lead sponsor:** Ullevaal University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 1001 (ACTUAL)
- **Last updated:** 2011-03-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00222261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00222261, "Aspirin Non-responsiveness and Clopidogrel Endpoint Trial.". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT00222261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*